You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Food companies have developed a tool to track cloned livestock to help ease public concerns.
Blogger Sandra Porter starts a series on the key steps to take in starting research on a genetic disease.
A blogger compares academia to the "real world."
Human Genome Sciences reports good news from animal studies of its anthrax drug.
Biogen Idec signs on the first tenant for its Innovation Incubator program.
An article in BusinessWeek says that supercomputing is coming to a desktop near you.
A British Nobel laureate criticizes the government for not placing a fair value on understanding scientific issues.
Wired blogs about the new editor-in-chief of Science.
The SciAm 50 awards are released.
Discover magazine reports on personal genomics and whether it's worth getting your genome tested.
The New York Times reports that universities are testing a new model of accepting money from companies to allow access to their researchers.
A blogger says that synthetic biology shouldn't be as scary as opponents make it out to be.
WSJ profiles Novartis' work with using genomics to develop vaccines.
Slate offers an explanation of how scientists determined there was a high proportion of African heritage in Jim Watson's genome.
LA Times has a Q&A with Francis Collins, who just won a lung research award.
Paging Dr. Eisen ... Science Commons announces a new protocol to encourage open access.
California's stem cell agency just can't stay out of trouble.
Blogger Keith Robison wonders what companies mean when they say "it's in our DNA."
A new tomography approach gets down to 3 nm resolution for a 3-D look at proteins in cells.
PGP participant John Halamka blogs about good conflict resolution practices.
Today, Science reports on a CTD code, a central lab in London, methane-producing microbes, and more.
WSJ issues a caveat emptor for consumers interesting in genetic testing.
More bad news for the pharma/biotech sector.
A blogger says that medical scientists, not major genome centers, should be directing the human microbiome project.
Nature focuses on proteomics, small RNAs, a new systems biology consortium, and more.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.